[Analysis of blood coagulation factors in patients undergoing surgery due to endometrial cysts].

OBJECTIVES The study was undertaken to evaluate selected blood coagulation factors in patients undergoing surgery, due to endometrial cysts and other ovarian benign cysts. MATERIALS AND METHODS Women involved in our study had not received any previous treatment for endometriosis and they had no history of any prior haemostatic disorders. Blood samples were collected before surgery and investigated for plasminogen, alpha2-antyplasmin, PAI-1 and tPA activity. As a control group, we have analyzed patients with benign gynecological diseases treated in our Department. RESULTS We have noticed higher mean concentration of plasminogen and alpha2-antyplasmin and lower mean concentration of PAI-1 and tPA activity in our patients in comparison with control group. Obtained results did not show any statistical significance. CONCLUSIONS Our analysis of haemostatic factors in blood samples did not show coagulation disorders in patients with endometriosis. Maybe there are only local coagulation disorders in endometrial tissue and its surrounding. In our opinion this problem requires further research and taking into consideration other factors.

[1]  J. Gilabert-Estellés,et al.  Plasminogen activators and plasminogen activator inhibitors in endometriosis. , 2005, Frontiers in bioscience : a journal and virtual library.

[2]  A. Bergqvist,et al.  Basal release of urokinase plasminogen activator, plasminogen activator inhibitor-1, and soluble plasminogen activator receptor from separated and cultured endometriotic and endometrial stromal and epithelial cells. , 2005, Fertility and sterility.

[3]  T. Kooistra,et al.  A role for the fibrinolytic system in postsurgical adhesion formation. , 2005, Fertility and sterility.

[4]  G. Edelstam,et al.  Fibrinolysis in the Peritoneal Fluid During Adhesions, Endometriosis and Ongoing Pelvic Inflammatory Disease , 1998, Inflammation.

[5]  A. Bergqvist,et al.  Fibrinolytic factors in endometriotic tissue, endometrium, peritoneal fluid, and plasma from women with endometriosis and in endometrium and peritoneal fluid from healthy women. , 1998, Fertility and sterility.

[6]  S. Prifti,et al.  Soluble urokinase-type plasminogen activator receptor is over-expressed in uterine endometrium from women with endometriosis. , 1997, Molecular human reproduction.

[7]  C. Lindoff,et al.  Treatment with a GnRH analogue: effects on hemostatic risk factors for thrombo-embolic disease. , 1994, International journal of fertility and menopausal studies.

[8]  B. Bennett,et al.  Fibrinolysis and thrombosis. , 1994, Bailliere's clinical haematology.

[9]  A. Schindler,et al.  Plasmatic haemostasis in gonadotrophin-releasing hormone analogue therapy: effects of leuprorelin acetate depot on coagulatory and fibrinolytic activities. , 1992, Clinical therapeutics.

[10]  G. Dunselman,et al.  Fibrinolytic properties of peritoneal fluid in endometriosis. , 1988, Gynecologic and obstetric investigation.